Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a minor update to the revision history.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows Revision: v3.6.4, updating the previous v3.6.3. This appears to be a small maintenance update rather than a change to study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a small version update to the page template.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page shows a new revision tag: Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects an update to the page's revision metadata rather than substantive study information.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows that recruitment has ended ('No longer looking for participants') and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Interventions/Treatment heading is added while the previous 'Intervention / Treatment' heading is removed, and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check65 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This appears to be a minor maintenance update rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.